Contact Us
Drug Search Results
More Filters [+]

Sertindole

Alternative Names: sertindole, serdolect
Latest Update: 2024-11-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Belgium | Bulgaria | Croatia | Czech | Denmark | Egypt | Estonia | Finland | Germany | Greece | Hungary | Iceland | Ireland | Israel | Italy | Latvia | Netherlands | New Zealand | Norway | Poland | Portugal | Romania | Russia | Slovakia | Spain | Sweden | Switzerland | Turkey | Ukraine | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Lundbeck
Company Location: DENMARK G7 00000
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sertindole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Schizophrenia|Other

Phase 3: Schizophrenia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
H-A-2008-062

P4

Terminated

Schizophrenia

2013-07-01

SEROLA

N/A

Terminated

Schizophrenia

2012-11-01

98_PPI-P50

N/A

Terminated

Schizophrenia

2012-08-01

SEROLA

P4

Terminated

Schizophrenia

2012-03-31

Recent News Events

Date

Type

Title

02/06/2024

PubMed

 Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.

11/01/2023

PubMed

 The cellular mechanism of antipsychotic-induced myocarditis: A systematic review.

10/21/2023

PubMed

 Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions